Platform-as-a-Service
HOP Watchtm & analytics platform deployed via collaborative agreement with research institutions, university and Pharmas.
BUSINESS MODEL
IP-as-a-Service
Background & arising IP license agreements
Biomarker-as-a-Service
Pharma partners license validated IP (biomarkers, algorithms)
Confirmed “market pull” for clinical endpoints in drug discovery
